CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws. Sabahi M, Fathi Jouzdani A, Sadeghian Z, Dabbagh Ohadi MA, et al. J Neurooncol 2024 Nov 13. doi: 10.1007/s11060-024-04876.

Read + Share

Amedeo Smart

Independent Medical Education

Sabahi M, Fathi Jouzdani A, Sadeghian Z, Dabbagh Ohadi MA, et al. CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws. J Neurooncol 2024 Nov 13. doi: 10.1007/s11060-024-04876.
PMID: 39538038